
|Articles|July 12, 2013
Supplements and Featured Publications
- The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Pa
- Volume 19
- Issue 10 Suppl
Post Test: The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes
Advertisement
Instructions
After reading “The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Patient Management and Outcomes,” complete the program evaluation and select the single best answer to each of the posttest questions.
A statement of continuing education credit will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.
Articles in this issue
over 13 years ago
Optimizing Therapy and Management of Neurogenic Bladderover 13 years ago
The Epidemiology and Pathophysiology of Neurogenic BladderAdvertisement
Related to this article

The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
3
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
4
MM’s Vulnerability to CAR T Was a Happy Surprise: Nikhil C. Munshi, MD
5

